XML 42 R30.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue recognition and accounts receivable (Tables)
6 Months Ended
Jun. 30, 2023
Revenue Recognition And Accounts Receivable [Abstract]  
Schedule of Net Sales by Major Product Category by Reporting Segment

The table below presents net sales by major product category by reporting segment:

 

 

 

Three Months Ended June 30,

 

(Unaudited, U.S. Dollars, in thousands)

 

2023

 

 

2022

 

 

Change

 

Bone Growth Therapies

 

$

52,662

 

 

$

47,765

 

 

 

10.3

%

Spinal Implants, Biologics, and Enabling Technologies

 

 

105,314

 

 

 

43,017

 

 

 

144.8

%

Global Spine

 

 

157,976

 

 

 

90,782

 

 

 

74.0

%

Global Orthopedics

 

 

29,040

 

 

 

27,288

 

 

 

6.4

%

Net sales

 

$

187,016

 

 

$

118,070

 

 

 

58.4

%

 

 

 

Six Months Ended June 30,

 

(Unaudited, U.S. Dollars, in thousands)

 

2023

 

 

2022

 

 

Change

 

Bone Growth Therapies

 

$

100,376

 

 

$

89,713

 

 

 

11.9

%

Spinal Implants, Biologics, and Enabling Technologies

 

 

206,806

 

 

 

83,724

 

 

 

147.0

%

Global Spine

 

 

307,182

 

 

 

173,437

 

 

 

77.1

%

Global Orthopedics

 

 

55,038

 

 

 

51,051

 

 

 

7.8

%

Net sales

 

$

362,220

 

 

$

224,488

 

 

 

61.4

%

Schedule of Components Net Sales

The table below presents product sales and marketing service fees, which are both components of net sales:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(Unaudited, U.S. Dollars, in thousands)

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Product sales

 

$

174,078

 

 

$

103,559

 

 

$

336,326

 

 

$

196,167

 

Marketing service fees

 

 

12,938

 

 

 

14,511

 

 

 

25,894

 

 

 

28,321

 

Net sales

 

$

187,016

 

 

$

118,070

 

 

$

362,220

 

 

$

224,488

 

Allowances for Expected Credit Losses

The following table provides a detail of changes in the Company’s allowance for expected credit losses for the three and six months ended June 30, 2023 and 2022:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(Unaudited, U.S. Dollars, in thousands)

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Allowance for expected credit losses beginning balance

 

$

6,691

 

 

$

5,389

 

 

$

6,419

 

 

$

4,944

 

Addition resulting from the Merger with SeaSpine

 

 

 

 

 

 

 

 

137

 

 

 

 

Current period provision for expected credit losses

 

 

282

 

 

 

539

 

 

 

490

 

 

 

1,139

 

Write-offs charged against the allowance and other

 

 

6

 

 

 

(142

)

 

 

(120

)

 

 

(246

)

Effect of changes in foreign exchange rates

 

 

36

 

 

 

(197

)

 

 

89

 

 

 

(248

)

Allowance for expected credit losses ending balance

 

$

7,015

 

 

$

5,589

 

 

$

7,015

 

 

$

5,589